This case study shows how people with diabetes on SGLT2 inhibitors can develop a type of diabetic ketoacidosis (DKA) that’s easy to miss – but knowing the warning signs can help you stay safe. Read Natalie’s story and learn what everyone on SGLT2s should know.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/09/dka-type-2-diabetes-case-study/" align="left"]
SGLT2s have been popular in the type 2 diabetes world for years now, due to their cardiovascular benefits, kidney protection, ability to reduce A1c, and influence on weight loss. Dr. Preethika Ekanayake discusses the benefits (and the risks) for use in T1D.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/07/sglt2-inhibitors-in-type-1-diabetes-friend-or-foe/" align="left"]
We are fortunate to have many medications today to treat type 2 diabetes. Beyond improving glucose levels, some of these medications also have beneficial effects on other conditions that are common in people with type 2, such as heart failure and diabetic kidney disease.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/10/medications-and-other-treatment-options-to-reduce-complications-from-type-2-diabetes/" align="left"]
With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/10/cardiovascular-benefits-of-sglt2-inhibitors-glp-1-ras/" align="left"]
